Literature DB >> 17890681

Anionic lipids activate group IVA cytosolic phospholipase A2 via distinct and separate mechanisms.

Preeti Subramanian1, Mohsin Vora, Luciana B Gentile, Robert V Stahelin, Charles E Chalfant.   

Abstract

Previously, ceramide-1-phosphate (C1P) and phosphatidylinositol-4,5-bisphosphate [PI(4,5)P2] were demonstrated to be potent and specific activators of group IVA cytosolic phospholipase A2 (cPLA2alpha). In this study, we hypothesized that these anionic lipids functionally activated the enzyme by distinctly different mechanisms. Indeed, surface plasmon resonance and surface dilution kinetics demonstrated that C1P was a more potent effector than PI(4,5)P2 in decreasing the dissociation constant of the cPLA2alpha-phosphatidylcholine (PC) interaction and increasing the residence time of the enzyme on the vesicles/micelles. PI(4,5)P2, in contrast to C1P, decreased the Michaelis-Menten constant, increasing the catalytic efficiency of the enzyme. Furthermore, PI(4,5)P2 activated cPLA2alpha with a stoichiometry of 1:1 versus C1P at 2.4:1. Lastly, PI(4,5)P2, but not C1P, increased the penetration ability of cPLA2alpha into PC-rich membranes. Therefore, this study demonstrates two distinct mechanisms for the activation of cPLA2alpha by anionic lipids. First, C1P activates cPLA2alpha by increasing the residence time of the enzyme on membranes. Second, PI(4,5)P2 activates the enzyme by increasing catalytic efficiency through increased membrane penetration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890681     DOI: 10.1194/jlr.M700356-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  20 in total

1.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

Review 2.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

3.  Lactosylceramide interacts with and activates cytosolic phospholipase A2α.

Authors:  Hiroyuki Nakamura; Yuta Moriyama; Tomohiko Makiyama; Shunsuke Emori; Hisahiro Yamashita; Risa Yamazaki; Toshihiko Murayama
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

4.  Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis.

Authors:  Michael Holinstat; Olivier Boutaud; Patrick L Apopa; Joanne Vesci; Manju Bala; John A Oates; Heidi E Hamm
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-02       Impact factor: 8.311

5.  Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.

Authors:  Hiroyuki Nakamura; Shigeo Wakita; Akiko Suganami; Yutaka Tamura; Kentaro Hanada; Toshihiko Murayama
Journal:  J Lipid Res       Date:  2009-10-16       Impact factor: 5.922

6.  The cationic cluster of group IVA phospholipase A2 (Lys488/Lys541/Lys543/Lys544) is involved in translocation of the enzyme to phagosomes in human macrophages.

Authors:  Javier Casas; Martín Valdearcos; José Pindado; Jesús Balsinde; María A Balboa
Journal:  J Lipid Res       Date:  2009-08-28       Impact factor: 5.922

7.  Ceramide 1-phosphate is required for the translocation of group IVA cytosolic phospholipase A2 and prostaglandin synthesis.

Authors:  Nadia F Lamour; Preeti Subramanian; Dayanjan S Wijesinghe; Robert V Stahelin; Joseph V Bonventre; Charles E Chalfant
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

Review 8.  Phospholipases A2 and inflammatory responses in the central nervous system.

Authors:  Grace Y Sun; Phullara B Shelat; Michael B Jensen; Yan He; Albert Y Sun; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2009-10-24       Impact factor: 3.843

Review 9.  Phospholipase A2 biochemistry.

Authors:  John E Burke; Edward A Dennis
Journal:  Cardiovasc Drugs Ther       Date:  2008-10-18       Impact factor: 3.727

10.  Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Authors:  Satoru Niwa; Nicole Urtz; Thomas Baumruker; Andreas Billich; Frédéric Bornancin
Journal:  Lipids Health Dis       Date:  2010-01-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.